143 related articles for article (PubMed ID: 37009089)
1. Vitreous Seed Classification and Regression Patterns in Eyes With Retinoblastoma.
Rishi P; Attiku Y; Manchegowda PT; Agarwal A; Sharma M
J Vitreoretin Dis; 2021; 5(2):121-129. PubMed ID: 37009089
[TBL] [Abstract][Full Text] [Related]
2. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal Topotecan for Vitreous Seeds in Retinoblastoma: A Long-term Review of 91 Eyes.
Sen M; Rao R; Mulay K; Reddy VAP; Honavar SG
Ophthalmology; 2024 May; ():. PubMed ID: 38703794
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
Shields CL; Manjandavida FP; Arepalli S; Kaliki S; Lally SE; Shields JA
JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
[TBL] [Abstract][Full Text] [Related]
5. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
[TBL] [Abstract][Full Text] [Related]
6. The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan.
Francis JH; Abramson DH; Gaillard MC; Marr BP; Beck-Popovic M; Munier FL
Ophthalmology; 2015 Jun; 122(6):1173-9. PubMed ID: 25795478
[TBL] [Abstract][Full Text] [Related]
7. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma.
Rao R; Honavar SG; Sharma V; Reddy VAP
Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients.
Bogan CM; Pierce JM; Doss SD; Tao YK; Chen SC; Boyd KL; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
Exp Eye Res; 2021 Mar; 204():108439. PubMed ID: 33444583
[TBL] [Abstract][Full Text] [Related]
10. Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.
Francis JH; Iyer S; Gobin YP; Brodie SE; Abramson DH
Ophthalmology; 2017 Oct; 124(10):1548-1555. PubMed ID: 28545735
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Group D Retinoblastoma With Resistant Vitreous Seeds After Integration of Intravitreal Chemotherapy to the Treatment Protocol.
Amin S; Rizvi F; Zia N; Ali A; Hamid A; Kumari B
Cureus; 2020 Nov; 12(11):e11757. PubMed ID: 33409006
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma.
Kiratli H; Koç I; Öztürk E; Varan A; Akyüz C
Jpn J Ophthalmol; 2020 Jul; 64(4):351-358. PubMed ID: 32447585
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China.
Ji X; Hua P; Li J; Li J; Zhao J; Zhao P
J Ophthalmol; 2016; 2016():4387286. PubMed ID: 26977313
[TBL] [Abstract][Full Text] [Related]
14. Periocular topotecan for vitreous seeds in retinoblastoma.
Sthapit PR; Rao R; Honavar SG
Indian J Ophthalmol; 2018 Dec; 66(12):1833-1838. PubMed ID: 30451190
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma.
Kiratli H; Koç İ; Varan A; Akyüz C
Eur J Ophthalmol; 2017 Jun; 27(4):423-427. PubMed ID: 28106239
[TBL] [Abstract][Full Text] [Related]
16. Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma.
Riazi-Esfahani H; Masoomian B; Khodabandeh A; Amini A; Taghizadeh S; Boujabadi L; Sharifkashani S; Shields CL; Ghassemi F
Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1167-1175. PubMed ID: 36401651
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study.
Bogan CM; Kaczmarek JV; Pierce JM; Chen SC; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Nadelmann JB; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
Br J Ophthalmol; 2022 Feb; 106(2):288-296. PubMed ID: 33972235
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal Melphalan Chemotherapy for Vitreous Seeds in Retinoblastoma.
Yousef YA; Noureldin AM; Sultan I; Deebajah R; Al-Hussaini M; Shawagfeh M; Mehyar M; Mohammad M; Jaradat I; AlNawaiseh I
J Ophthalmol; 2020; 2020():8628525. PubMed ID: 32047663
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of posterior sub-Tenon's carboplatin injection versus intravitreal melphalan therapy in the management of retinoblastoma with secondary vitreous seeds.
Said AMA; Aly MG; Rashed HO; Rady AM
Int J Ophthalmol; 2018; 11(3):445-455. PubMed ID: 29600179
[TBL] [Abstract][Full Text] [Related]
20. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
